Business Daily from THE HINDU group of publications
Monday, November 30, 2009
ePaper | Mobile/PDA Version | Audio | Blogs
News
Features
Stocks
Foreign Exchange
Shipping
Archives
Google

Subscription

Group Sites

Resources
Cipla Ltd
Nifty 50
  • Cipla raises Rs 671 crore through QIP (September 24, 2009)
  • Cipla urges Govt to allow retail sale of anti-flu drugs (August 27, 2009)
  • Cipla (Rs 257.7): Sell (August 21, 2009)
  • Cipla gets notices for alleged overcharging (July 10, 2009)
  • Cipla's swine flu drug in WHO list (May 14, 2009)
  • Cipla Q4 net profit up on better product-mix (April 25, 2009)
  • Cipla does not support Adcock proposal to buy Cipla Medpro (April 19, 2009)
  • Cipla can benefit if Medpro acquisition goes through (April 10, 2009)
  • Patents yes, but monopoly no (February 25, 2009)
  • Concern over access to next-gen AIDS drugs (February 06, 2009)
  • Cipla export consignment too seized at Amsterdam (February 04, 2009)
  • Cipla Q3 net up; sales post growth (January 23, 2009)

    Year : 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002

    • The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
    Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

    Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line